| ARRQX | VTSMX | ARRQX / VTSMX | |
| Total Expense Ratio | 0.61 | 0.14 | 436% |
| Annual Report Gross Expense Ratio | 0.62 | 0.14 | 443% |
| Fund Existence | 2 years | 34 years | - |
| Gain YTD | 10.289 | 15.972 | 64% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 515M | 2.05T | 0% |
| Annual Yield % from dividends | 1.57 | 1.02 | 154% |
| Returns for 1 year | 2.27 | 13.42 | 17% |
| Returns for 3 years | N/A | 68.22 | - |
| Returns for 5 years | N/A | 83.98 | - |
| Returns for 10 years | N/A | 235.40 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBGB | 25.26 | 0.16 | +0.62% |
| iShares iBonds Dec 2045 Term Trsy ETF | |||
| SBIO | 46.19 | 0.12 | +0.26% |
| ALPS Medical Breakthroughs ETF | |||
| ASET | 34.27 | N/A | N/A |
| FlexShares Real Assets Allocation Index Fund | |||
| FXY | 59.41 | -0.27 | -0.45% |
| Invesco CurrencyShares® Japanese Yen | |||
| ICF | 61.33 | -0.51 | -0.82% |
| iShares Select U.S. REIT ETF | |||